Bausch & Lomb (BLCO) Research & Development (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Research & Development came in at $114.0 million in Q2 2026, up 18.75% YoY from $96.0 million in Q2 2025, and up 12.87% on a QoQ basis from $101.0 million in Q1 2026.
Bausch & Lomb (BLCO) Research & Development (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Research & Development data on file, last reported at $114.0 million in Q2 2026.
- Quarterly Research & Development rose 18.75% year-over-year to $114.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $404.0 million (up 12.53% YoY) and the FY2025 annual result came in at $371.0 million, up 8.16% from the prior year.
- Research & Development improved to $114.0 million in Q2 2026, from $101.0 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $114.0 million in Q2 2026 to a low of $75.0 million in Q2 2022.
- A 5-year average of $86.7 million and a median of $84.0 million in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development grew 22.22% — and 2024, when it declined 1.18%.
- Tracing BLCO's Research & Development over 5 years: stood at $78.0 million in 2022, then climbed by 2.56% to $80.0 million in 2023, then advanced by 16.25% to $93.0 million in 2024, then advanced by 1.08% to $94.0 million in 2025, then gained by 21.28% to $114.0 million in 2026.
- The last three Research & Development figures came in at $114.0 million (Q2 2026), $101.0 million (Q1 2026), and $94.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Bausch & Lomb | 6.16 Bn | 5.78 Bn | 867.00 Mn | 114.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 114.00 Mn |
| Mar 31, 2026 | 101.00 Mn |
| Dec 31, 2025 | 94.00 Mn |
| Sep 30, 2025 | 95.00 Mn |
| Jun 30, 2025 | 96.00 Mn |
| Mar 31, 2025 | 86.00 Mn |
| Dec 31, 2024 | 93.00 Mn |
| Sep 30, 2024 | 84.00 Mn |
| Jun 30, 2024 | 84.00 Mn |
| Mar 31, 2024 | 82.00 Mn |
| Dec 31, 2023 | 80.00 Mn |
| Sep 30, 2023 | 82.00 Mn |
| Jun 30, 2023 | 85.00 Mn |
| Mar 31, 2023 | 77.00 Mn |
| Dec 31, 2022 | 78.00 Mn |
| Sep 30, 2022 | 77.00 Mn |
| Jun 30, 2022 | 75.00 Mn |
| Mar 31, 2022 | 77.00 Mn |
| Dec 31, 2021 | 70.00 Mn |
| Sep 30, 2021 | 63.00 Mn |